64 related articles for article (PubMed ID: 3623048)
21. S-phase rate as a predictor of early recurrences in carcinoma of the uterine cervix.
Strang P; Eklund G; Stendahl U; Frankendal B
Anticancer Res; 1987; 7(4B):807-10. PubMed ID: 3674766
[TBL] [Abstract][Full Text] [Related]
22. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM
Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
[TBL] [Abstract][Full Text] [Related]
23. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
[TBL] [Abstract][Full Text] [Related]
25. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of DNA ploidy status in patients with rectal cancer.
Berczi C; Bocsi J; Bartha I; Math J; Balazs G
Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
[TBL] [Abstract][Full Text] [Related]
27. Ovarian tumors of low malignant potential. Correlation of DNA index and S-phase fraction with histopathologic grade and clinical outcome.
Demirel D; Laucirica R; Fishman A; Owens RG; Grey MM; Kaplan AL; Ramzy I
Cancer; 1996 Apr; 77(8):1494-500. PubMed ID: 8608534
[TBL] [Abstract][Full Text] [Related]
28. [Extent of psammoma carcinomas of the ovary--a clinical, DNA flow cytophotometric and morphometric image analysis study].
Kühn W; Feichter GE; Beier K; Rummel HH; Abel U; Kaufmann M
Geburtshilfe Frauenheilkd; 1990 Aug; 50(8):597-604. PubMed ID: 2170226
[TBL] [Abstract][Full Text] [Related]
29. [Clinical course of ovarian cancer in relation to morphologic prognostic factors and cell kinetic parameters].
Kühn W; Feichter GE; Hanke J; Rummel HH; Kaufmann M; Schmid H
Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):446-51. PubMed ID: 3623047
[TBL] [Abstract][Full Text] [Related]
30. Association of p53 expression with proliferative activity and poor-prognosis in patients with squamous-cell lung carcinomas.
Volm M; Mattern J; Hecker S; Pommerenke E
Int J Oncol; 1994 Sep; 5(3):533-8. PubMed ID: 21559609
[TBL] [Abstract][Full Text] [Related]
31. DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors.
Kühn W; Kaufmann M; Feichter GE; Rummel HH; Schmid H; Heberling D
Gynecol Oncol; 1989 Jun; 33(3):360-7. PubMed ID: 2722063
[TBL] [Abstract][Full Text] [Related]
32. Flow-cytometric prognostic factors for the survival of patients with ovarian carcinoma: a 5-year follow-up study.
Volm M; Kleine W; Pfleiderer A
Gynecol Oncol; 1989 Oct; 35(1):84-9. PubMed ID: 2792909
[TBL] [Abstract][Full Text] [Related]
33. [Prognostic significance of DNA ploidy and distribution of cell cycle phases in non-small cell bronchial cancer. A 5-year survival study].
Volm M
Versicherungsmedizin; 1989 Jan; 41(1):2-5. PubMed ID: 2536509
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometric analysis of DNA content in human ovarian cancers.
Erba E; Ubezio P; Pepe S; Vaghi M; Marsoni S; Torri W; Mangioni C; Landoni F; D'Incalci M
Br J Cancer; 1989 Jul; 60(1):45-50. PubMed ID: 2803914
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the prognostic value of morphometric features and cellular DNA content in FIGO I ovarian cancer patients.
Baak JP; Wisse-Brekelmans EC; Uyterlinde AM; Schipper NW
Anal Quant Cytol Histol; 1987 Aug; 9(4):287-90. PubMed ID: 3663312
[TBL] [Abstract][Full Text] [Related]
36. [Quantitative DNA determination and its role in the prognosis of malignant tumors].
Krug H
Zentralbl Allg Pathol; 1985; 130(4):333-40. PubMed ID: 4090763
[TBL] [Abstract][Full Text] [Related]
37. Flow cytometric measurement of ploidy and proliferation in effusions of ovarian carcinoma and their possible prognostic significance.
Sahni K; Tribukait B; Einhorn N
Gynecol Oncol; 1989 Nov; 35(2):240-5. PubMed ID: 2807018
[TBL] [Abstract][Full Text] [Related]
38. Analysis of ascites from patients with ovarian carcinoma by cell flow cytometry.
Rotmensch J; Atcher RW; Schwartz JL; Grdina DJ
Gynecol Oncol; 1992 Jan; 44(1):10-2. PubMed ID: 1730415
[TBL] [Abstract][Full Text] [Related]
39. DNA content and proliferative activity in ovarian small cell carcinomas of the hypercalcemic type. Implications for diagnosis, prognosis, and histogenesis.
Eichhorn JH; Bell DA; Young RH; Swymer CM; Flotte TJ; Preffer RI; Scully RE
Am J Clin Pathol; 1992 Dec; 98(6):579-86. PubMed ID: 1334364
[TBL] [Abstract][Full Text] [Related]
40. DNA index of ovarian carcinomas from 56 patients: in vivo in vitro studies.
Erba E; Vaghi M; Pepe S; Amato G; Bistolfi M; Ubezio P; Mangioni C; Landoni F; Morasca L
Br J Cancer; 1985 Oct; 52(4):565-73. PubMed ID: 4063134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
